Literature DB >> 22440257

Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation.

Shinwu Jeong1, Dolena R Ledee, Gabriel M Gordon, Tatsuo Itakura, Nitin Patel, Aaron Martin, M Elizabeth Fini.   

Abstract

Uncontrolled increases of matrix metalloproteinase-9 (MMP-9) activity have been causally linked to epithelial barrier disruption and severe symptoms of inflammatory diseases such as dry eye (DE). The data presented here show that the anti-inflammatory, cytoprotective intracellular and extracellular chaperone protein clusterin (CLU) interacts with MMP-9 both inside and outside epithelial cells. CLU bound very strongly to active MMP-9, with an affinity constant K(D) of 2.63 nmol/L. Unexpectedly, CLU had a much higher affinity for pro-MMP-9 than for active MMP-9 or pro-MMP-2, requiring the N-terminal propeptide domain of pro-MMP-9. The significance of the interaction between CLU and MMP-9 was demonstrated by the observation that CLU prevents stress-induced MMP-9 aggregation and inhibits MMP-9 enzymatic activity. Furthermore, CLU inhibited MMP-9-mediated disintegration of the tight junction structure formed between human epithelial cells. Additionally, CLU inhibited enzymatic activities of MMP-2, MMP-3, and MMP-7. Treatment with proinflammatory cytokines, which are known to increase MMP-9 transcription under inflammatory conditions, reduced the expression of CLU in human epithelial cells. Similarly, in a mouse model of human DE, inflammatory stress depleted CLU in the ocular surface epithelium but allowed MMP-9 to prevail therein. The present results thus provide novel insights into previously unrecognized mechanisms by which CLU maintains fluid-epithelial interface homeostasis, thereby preventing the onset of inflammatory conditions, especially where MMP-9 is actively involved.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440257      PMCID: PMC3349834          DOI: 10.1016/j.ajpath.2012.01.025

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  72 in total

1.  Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.

Authors:  Lihui Luo; De-Quan Li; Amish Doshi; William Farley; Rosa M Corrales; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-12       Impact factor: 4.799

2.  Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization.

Authors:  O Y Barmina; H W Walling; G J Fiacco; J M Freije; C López-Otín; J J Jeffrey; N C Partridge
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

3.  Advances and challenges in basic and translational research on clusterin.

Authors:  Ioannis P Trougakos; Julie Y Djeu; Efstathios S Gonos; David A Boothman
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

4.  Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells.

Authors:  Gabriel M Gordon; Dolena R Ledee; William J Feuer; M Elizabeth Fini
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

5.  MMP9 modulates tight junction integrity and cell viability in human airway epithelia.

Authors:  Paola D Vermeer; James Denker; Miriam Estin; Thomas O Moninger; Shaf Keshavjee; Philip Karp; Joel N Kline; Joseph Zabner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-06       Impact factor: 5.464

6.  Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.

Authors:  Han-Jong Kim; Eun-Kyung Yoo; Joon-Young Kim; Young-Keun Choi; Hyo-Jeong Lee; Jeong-Kook Kim; Nam Ho Jeoung; Ki-Up Lee; In-Sun Park; Bon-Hong Min; Keun-Gyu Park; Chul-Ho Lee; Bruce J Aronow; Masataka Sata; In-Kyu Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-20       Impact factor: 8.311

7.  Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2.

Authors:  M W Olson; D C Gervasi; S Mobashery; R Fridman
Journal:  J Biol Chem       Date:  1997-11-21       Impact factor: 5.157

8.  Structural characterization of clusterin-chaperone client protein complexes.

Authors:  Amy R Wyatt; Justin J Yerbury; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

9.  Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.

Authors:  U Schönbeck; F Mach; P Libby
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome.

Authors:  Suksri Chotikavanich; Cintia S de Paiva; De Quan Li; Joseph J Chen; Fang Bian; William J Farley; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-28       Impact factor: 4.799

View more
  36 in total

1.  Inorganic polyphosphate induces accelerated tube formation of HUVEC endothelial cells.

Authors:  Werner E G Müller; Maximilian Ackermann; Shunfeng Wang; Meik Neufurth; Rafael Muñoz-Espí; Qingling Feng; Heinz C Schröder; Xiaohong Wang
Journal:  Cell Mol Life Sci       Date:  2017-08-02       Impact factor: 9.261

2.  Increased extracellular clusterin in the prefrontal cortex in schizophrenia.

Authors:  Katina M Athanas; Sarah L Mauney; Tsung-Ung W Woo
Journal:  Schizophr Res       Date:  2015-10-21       Impact factor: 4.939

3.  Altered gene expression in conjunctival squamous cell carcinoma.

Authors:  Alka Mahale; Hind Alkatan; Saeed Alwadani; Maha Othman; Maria J Suarez; Antoinette Price; Hailah Al-Hussain; Sabah Jastaneiah; Wayne Yu; Azza Maktabi; Edward P Deepak; Charles G Eberhart; Laura Asnaghi
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

Review 4.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 5.  Gastrointestinal mucositis: the role of MMP-tight junction interactions in tissue injury.

Authors:  Noor Al-Dasooqi; Hannah R Wardill; Rachel J Gibson
Journal:  Pathol Oncol Res       Date:  2014-01-15       Impact factor: 3.201

6.  Longitudinal proteomics analysis in the immediate microenvironment of islet allografts during progression of rejection.

Authors:  Oscar Alcazar; Luis F Hernandez; Ernesto S Nakayasu; Paul D Piehowski; Charles Ansong; Midhat H Abdulreda; Peter Buchwald
Journal:  J Proteomics       Date:  2020-05-20       Impact factor: 4.044

Review 7.  Update on the role of impression cytology in ocular surface disease.

Authors:  Zhang-Zhe Thia; Louis Tong
Journal:  Taiwan J Ophthalmol       Date:  2019-09-12

8.  Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results.

Authors:  Valerie Yu; Dhruva Bhattacharya; Andrew Webster; Aditi Bauskar; Charles Flowers; Martin Heur; Shravan K Chintala; Tatsuo Itakura; Mark R Wilson; Joseph T Barr; Shinwu Jeong; Mingwu Wang; M Elizabeth Fini
Journal:  Ocul Surf       Date:  2018-08-02       Impact factor: 5.033

9.  Highly abundant defense proteins in human sweat as revealed by targeted proteomics and label-free quantification mass spectrometry.

Authors:  É Csősz; G Emri; G Kalló; G Tsaprailis; J Tőzsér
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-08-25       Impact factor: 6.166

10.  Vitamin D Activation and Function in Human Corneal Epithelial Cells During TLR-Induced Inflammation.

Authors:  Rose Yvonne Reins; Hasna Baidouri; Alison Marie McDermott
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.